FZD7/WNT7b signaling have been identified as contributors to chemoresistance in pancreatic cancer [44].These genes were both elevated in Panc320 following treatment with ETC-159 and paclitaxel and may explain the persistent growth rate. This evidence concerns the gene FZD7 and familial pancreatic carcinoma.